BA
The Boeing Company
BA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
CDRE
Cadre Holdings, Inc.
CDRE has the edge over BA overall, supported by stronger modeled upside and lower modeled downside.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
CDRE Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Healthy | |
| Under pressure |
CDRE's revenue and cash flow are currently healthy, and its profitability is stable, but its balance sheet is under pressure.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over CDRE in the historical PE scenario, which offers more potential upside but is not a forecast.
CDRE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $33.08 | — |
| Cheap | 32x | $29.19 | -12% |
| Fair | 35x | $31.42 | -5% |
| Current | 37x | $33.08 | — |
| Expensive | 39x | $35.21 | +6.4% |
Historical ranges are pointers, not guarantees.
CDRE's PE is in its fair range at 37x. If earnings grow as analysts expect, today's price would be 23x next year's earnings, in its cheap range.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
CDRE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CDRE, with profitability improving. However, they disagree widely on these estimates.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over CDRE on earnings, with more consistent year-over-year improvement.
CDRE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.43 | +59% |
| Q3 2026 | $0.90 | -20% |
| Q2 2026 | $0.80 | -15% |
| Q1 2026 | $0.84 | -12% |
| Q4 2025 | $1.02 | +13% |
| Q3 2025 | $1.12 | +35% |
| Q2 2025 | $0.94 | -8.7% |
| Q1 2025 | $0.95 | -5.9% |
| Q4 2024 | $0.90 | -12% |
CDRE's earnings per share have fallen from their peak: $0.90 over the past year, against $1.21 in early 2021.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
CDRE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $202.9M | +30% |
| Q2 2026 | $207.1M | +32% |
| Q1 2026 | $155.4M | +19% |
| Q4 2025 | $167.2M | -5% |
| Q3 2025 | $155.9M | +42% |
| Q2 2025 | $157.1M | +8.9% |
| Q1 2025 | $130.1M | -5.6% |
| Q4 2024 | $176M | +41% |
CDRE's revenue is growing: $203M last quarter, up 30% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +2 points |
| Q2 2026 | 11% | +1.5 points |
| Q1 2026 | 4.8% | -5.6 points |
| Q4 2025 | 12% | -4.5 points |
| Q3 2025 | 12% | +7 points |
| Q2 2025 | 9.3% | -4.5 points |
| Q1 2025 | 10% | +1.7 points |
| Q4 2024 | 17% | +6.5 points |
CDRE has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over CDRE on cash flow, with more consistent year-over-year improvement.
CDRE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $19.9M | -8.2% |
| Q2 2026 | $18.7M | +1505% |
| Q1 2026 | $19.8M | +23% |
| Q4 2025 | $18M | -20% |
| Q3 2025 | $21.6M | +$27.9M |
| Q2 2025 | $1.2M | -87% |
| Q1 2025 | $16.1M | +1925% |
| Q4 2024 | $22.4M | -8.4% |
CDRE generated $76M in free cash flow over the past year, up 25% from the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has the edge over CDRE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CDRE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +77.4K shares |
| 1 year | +6.1% | +2.5M shares |
| 3 years | +15% | +5.5M shares |
| 5 years | +58% | +16M shares |
| Available history | +26% | +8.8M shares |
CDRE has 43M diluted shares, up 6.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
CDRE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 3.5x | Elevated |
| Q1 2026 | 4.0x | Elevated |
| Q4 2025 | 2.1x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 2.2x | Moderate |
| Q1 2025 | 1.0x | Healthy |
| Q4 2024 | 1.2x | Healthy |
CDRE's net debt is about 3.0 years of its operating earnings (EBITDA), up from 1.7 years a year ago.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
CDRE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.7 | Neutral |
| Stochastic | 65.2 | Neutral |
CDRE's weekly RSI is 58 (neutral) and its Stochastic is 65 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over CDRE on valuation relative to its sector.
CDRE PE vs Industrials Sector
| Metric | CDRE | Sector median | Relative |
|---|---|---|---|
| PE | 37x | 24x | 53% above |
| PE % | 65 | 66 | 1 pt below |
CDRE is trading at 37x earnings, a 53% premium to the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
CDRE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $28.5 | 16% above |
| 20 week MA | $29.7 | 11% above |
| 50 week MA | $33.6 | 1.4% below |
| 100 week MA | $34.0 | 2.7% below |
| 200 week MA | $31.9 | 3.8% above |
CDRE has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has the edge over CDRE on returns for 2026, with the stronger performance.
CDRE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $15.3 | $21.3 | +39% |
| 2022 | $21.3 | $20.1 | -5.4% |
| 2023 | $20.1 | $32.9 | +64% |
| 2024 | $32.9 | $32.1 | -2.6% |
| 2025 | $32.1 | $41.9 | +31% |
| 2026 YTD | $41.9 | $33.1 | -21% |
CDRE has finished higher in three of the last five years. It's down 21% so far in 2026.